Title : XPO1 expression worsens the prognosis of unfavorable DLBCL that can be effectively targeted by selinexor in the absence of mutant p53.

Pub. Date : 2020 Nov 4

PMID : 33148342






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Expression of Mut-p53 confers resistance to selinexor treatment, which can be overcome by combined INCB057643 treatment in HGBCL-DH cells. INCB-057643 tumor protein p53 Homo sapiens